Zinc Oxide Exempt from Pharmaceutical Tariffs
Key points
- Zinc oxide classified as a critical mineral, exempt from 100% tariffs on pharmaceuticals
- BASF raises prices of UV chemical filter ingredients by 30%
- Increase in debtor insurance claims of 158% in February
Full summary
Advance ZincTek Ltd has announced that zinc oxide, a key ingredient used in its products, is currently classified as a critical mineral by the US Geological Survey and Department of the Interior since 2022. This means that zinc oxide is exempt from the current proposed 100% tariffs on pharmaceuticals. The company also noted that on April 1, 2026, the UV chemical giant BASF has raised prices of ingredients used in their UV chemical filters by 30%. Additionally, a recent report from the credit insurer NCI has highlighted an increase in debtor insurance claims of 158% for the month of February. Despite these industry trends, Advance ZincTek Ltd remains debt-free with no debtors outside their trading terms. The company's sales for the period ending 31 March 2026 were $9.589 million, up 11.28% compared to the prior corresponding period of $8.617 million, based on unaudited management accounts.
Guidance
Sales to 31 March 2026 were $9.589 million, up 11.28% compared to the prior corresponding period.
Summary generated by a large language model. Please interpret with care.